Glaxosmithkline Share News (GSK)

UPDATE 1-EU agency backs approval of new GlaxoSmithKline melanoma drug

(Adds details on GSK drug) LONDON, April 25 (Reuters) - GlaxoSmithKline's melanoma drug Mekinist - one of several drugs being sold to Novartis under an asset swap deal - has been recommended for approval by European regulators. The European Medicines Agency (EMA) said on Friday its e

EU agency backs GSK melanoma drug, wider use of Bayer's Nexavar

LONDON, April 25 (Reuters) - European regulators said on Friday they had recommended approval of GlaxoSmithKline's melanoma drug Mekinist and also endorsed wider use of Bayer's Nexavar as a treatment for thyroid cancer. Mekinist is one of several drugs being sold to Novartis under an asse

AstraZeneca bid talk "a commercial matter" -UK finance minister

By William James CAMBRIDGE, England, April 25 (Reuters) - Talk of a $100 billion bid by U.S. drugmaker Pfizer for its British rival AstraZeneca is "a commercial matter between the companies", Britain's finance minister George Osborne said on Friday. Shares in Britain's second biggest

Lombard Medical To Leave AIM Following USD55 Million NASDAQ IPO

LONDON (Alliance News) - Lombard Medical Technology PLC Friday announced it has suspended trading on AIM, after it raised USD55 million in its initial public offering on the NASDAQ market in New York. The company's shares will be cancelled from the AIM market next Wednesday, when it will b

PRESS: Botox Maker Allergan Made Takeover Approach To Shire - Reuters

LONDON (Alliance News) - Botox maker Allergan Inc approached Ireland-based pharmaceutical firm Shire PLC about a possible takeover in recent months, but was rebuffed, Reuters reported late Thursday citing people familiar with the matter. The approach did not progress to serious discussions

CORRECTED-Novartis lung drug not inferior to GSK's Seretide, study shows

(Removes paragraph on QVA149, which refers to Ultibro Breezhaler not Onbrez Breezhaler) ZURICH, April 25 (Reuters) - Patients taking Novartis' inhaled medicine Onbrez Breezhaler for chronic lung disease had benefits similar to those taking GlaxoSmithKline's Seretide, the Swiss drugmaker s

GSK appoints new marketing, sales heads in China: source

By Adam Jourdan SHANGHAI, April 25 (Reuters) - British drugmaker GlaxoSmithKline Plc has appointed two executives to new roles overseeing sales and marketing in China after authorities accused the firm of corruption last year, a person with direct knowledge of the decision told Reuters.

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar

Read more 24 Apr 2014 15:51 UK Earnings, Trading Statements Calendar - Week Ahead UK Earnings, Trading Statements Calendar Read more 24 Apr 2014 12:16 UK MIDDAY BRIEFING: AstraZeneca Maintains Guidance Despite Profit Hit LONDON (Alliance News) - AstraZeneca shares jumped Thursday after the pharmaceutical giant maintained its full-year guidance for 2014, even as its pretax profit dropped in the first quarter to end-March, hit by write-downs on the sale of its Alderley Park site and its acquisit Read more 24 Apr 2014 05:14 UK Earnings, Trading Statements Calendar - Week Ahead UK Earnings, Trading Statements Calendar Read more 23 Apr 2014 17:53 Novartis-GSK asset swap offers template for pharma and beyond * Scope for deals in consumer goods sector * Asset swaps avoid merger pitfalls By Ben Hirschler, Martinne Geller and Anjuli Davies LONDON, April 23 (Reuters) - The loud welcome given by investors to this week's deal for Novartis and GlaxoSmithKline to trade more than $20 billion Read more 23 Apr 2014 16:04 MARKET COMMENT: UK Stocks Drift Down Ahead Of US Tech Bellwethers LONDON (Alliance News) - Stocks drifted lower across the UK and Europe Wednesday following the release of sluggish Chinese economic data. Despite some positive UK and European economic news, as well as some stand-out UK stock movers, equity indices are broadly lower as investors aw Read more 23 Apr 2014 15:29 UK Earnings, Trading Statements Calendar - Week Ahead UK Earnings, Trading Statements Calendar Read more 23 Apr 2014 11:59 RPT-Fitch: Novartis/GSK Deal Highlights Narrowing R&D Focus (Repeat for additional subscribers) April 23 (Reuters) - (The following statement was released by the rating agency) Novartis and GlaxoSmithKline's (GSK) asset swap deal highlights the industry's growing emphasis on efficiency through more focused research and development (R&D) and Read more 266267268269270271272273274 Stay Informed! With our newsletters and social media channels. Daily Market Report (Weekday Evenings)Week Ahead (Sunday Evening) Login to your account Login failed Remember MeSign In Don't have an account? Click here to register. Quickpicks are a member only feature Login to your account Login failed Remember MeSign In Don't have an account? Click here to register.